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We describe an improved method for the quantitation of total and direct bilirubin in serum in which sodium dodecyl sulfate is used as an accelerator.
Viscous and caustic reagents are not needed, and the effects of protein matrix, hemoglobin interference, and turbidity are minimized. For total bilirubin determination we first add the sodium dodecyl sulfate reagent to serum, then a diazo reagent that lowers the pH to 5.6, the effective pI(2 of maleic acid. After 10 mm we add sulfanilic#{149}HCI reagent to bring the pH to 1.55. For determination of conjugated bilirubin, we add the sulfanilic#{149}HCI reagent first, followed by the diazo reagent, an ascorbic acid solution, and finally, the sodium dodecyl sulfate reagent. The same sample blank is used for determination of both total and direct bilirubin. At 565 nm the molar absorptivity of azobilirubin determined with Standard
Reference Material 916 in human serum albumin, bovine serum albumin, and pooled serum is 82780 ± 496 L mo11cm1.
The absorptivity remains constant to within 0.3% in the pH range of 1.45 to 1.67. The color at both pH 5.6 and 1.55 is stable to within 0.1% for at least 1 h. The method is unaffected by protein concentrations of 2-120 gIL, has a linear standard curve to within 0.5% for bilirubin concentrations of 0-250 mg/L, and correlates well with the Jendrassik-Grof method by linear-regression analysis of 52 samples from patients (r = 0.999; slope, 1.02; yintercept, 0.27 mg/L). We discuss a mechanism to explain the effects of hemolysis on the coupling of the diazo reagent, and discuss the effects of several heme-binding agents that can be used to minimize such interference.
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The laboratory determination of bilirubin is most commonly performed by the Malloy-Evelyn (1, 2), the MeitesHogg (3), or the Jendrassik-Grof (4, 5) procedures. The Malloy-Evelyn and Meites-Hogg methods suffer from high blank absorbances, which result from sample turbidity, and a marked dependence on both the composition of the protein matrix and the concentration of endogenous hemoglobin. The Jendrassik-Grof method, which suffers less from sample turbidity and hemoglobin effects than the other methods, requires the use of caustic and viscous reagents. We report here the details of our method, which uses the detergent so- To whom correspondence should be addressed.
2 Nonstandard abbreviations used: SDS, sodium dodecyl sulfate;
BIL-BSA, a solution of bilirubin in a bovine serum albumin matrix; SRM, Standard Reference Material; Hb, hemoglobin.
dium dodecyl sulfate (SDS)2 to overcome the above difficulties in the determination of total and conjugated bilirubin. The use of detergents for bilirubin analysis has been reported by Perlman and Lee (6) , who used Duponol, and by Watanabe et al. (7), who used SDS. Inadequate attention to considerations of standardization, protein concentration, matrix effects, and pH optimization leads to low sensitivity and questionable accuracy in these methods. In developing our method we have relied extensively on the excellent approach of Doumas et al. (8) in their evaluation of the Malloy-Evelyn, the Meites-Hogg, and the Jendrassik-Grof methods. In an alternative but less desirable procedure, 14.5 g of maleic acid and 9.6 g of sodium hydroxide can replace the maleic acid disodium salt. It is critical to avoid an excess of sodium hydroxide to prevent excessive foaming.
Material and Methods

Apparatus
Although SDS is known to hydrolyze at low pH, we have found the reagent to be stable for this assay for at least six months.
Sulfanilic acid reagent. SDS Procedure Total bilirubin. To 0.1 mL of serum add 1.0 mL of the SDS reagent and mix well (we recommend vortex-mixing). Add 0.3 mL of the diazo reagent, mix well, wait 10 mm, then add 1.0 mL of the sulfanilic acid reagent. Prepare the blank exactly the same way but replace the diazo reagent with 0.3 mL of ascorbic acid reagent. Read absorbance at 565 nm against water. The ascorbic acid prevents oxidation of bilirubin in the blank, and does not absorb at 565 nm.
Conjugated
bilirubin.
To 0.1 mL of serum add 0.5 mL of the sulfanilic acid reagent and mix. Add 0.5 mL of the diazo reagent and mix. After 1 mm, add 0.3 mL of ascorbic acid reagent, then 1.0 mL of the SDS reagent; mix thoroughly. Use the same blank as in the procedure for the total bilirubin. Read absorbance at 565 nm. When the SDS is added, a slight turbidity may occur that will disappear immediately upon mixing (see Results and Discussion).
Jendrassik-Grof Procedure
Total bilirubin. To 0.1 mL of serum add 1.0 mL of the caffeine reagent and mix well. Ten minutes after adding 0.4 mL of the diazo reagent, add 0.6 mL of the alkaline tartrate reagent. Prepare the blank exactly the same way but replace the diazo reagent with 0.4 mL of the sulfanilic acid reagent. Read absorbance at 600 nm against water. Conjugated bilirubin. This method is a modification of that described by Gambino (5) . To 0.1 mL of serum add 0.95 mL of HC1 (0.05 mol/L); mix and add 0.4 mL of the diazo reagent.
After 1 mm, add 0.05 mL of ascorbic acid reagent, then add 0.6 mL of alkaline tartrate. For the blank, use 0.4 mL of sulfanilic acid in place of diazo reagent. Mix thoroughly and read absorbance at 600 nm against water.
Results and Discussion
Experimental Considerations
Maleic acid buffering capacity.
To obtain high buffering capacity at the pH of diazo coupling (about 5.6) and at the final pH (about 1.6), we examined the buffering capacity of were required for adequate buffering capacity, and such high concentrations were considered undesirable.
The best buffer system we found was maleic acid.
We prepared stock solutions (50 g/L) of SDS in 0.1,0.125, and 0.15 mol of maleic acid per liter and added 1.0 mL of a 200 mg/L standard of bilirubmn in bovine serum albumin (BIL-BSA) to 10 mL of each of these solutions. We then titrated the solutions with the sulfanilic acid reagent to simulate the diazo reagent. The results are shown in Figure 1 . It is evident that for the 0.125 molfL concentration, which is used in the SDS method, there is considerable buffering capacity at both the stage of diazo coupling and the stage at which the absorbance is determined.
The coupling occurs at a pH equal to the effective pK2 of 5.6, and the absorbance is read at a pH of 1.55, which is the effective pK1. Additional buffering at pH 1.55 is contributed by the HC1 (0.24 molfL) in the sulfanilic acid reagent. Even a 10% error in the total amount of sulfanilic acid reagent added will result in an insignificant pH error of only 0.05 at pH 1.55. (Table 2) , that the method is insensitive to sulfaniic acid concentrations between 2.5 and 6.7 g/L. We used a concentration of 6.7 g/L, to give the same total sulfanilic acid concentration in the SDS reaction mixture as in the Jendrassik-Grof method. Optimization of sodium nitrite. We added various amounts of the 5 g/L stock sodium nitrite reagent to 9-mL volumes of the 6.7 g/L sulfanilic acid reagent, which were subsequently used as diazo reagents.
The results of the absorption measurements on adding the diazo reagents to a 200 mg/L standard of BIL-BSA are shown in Table 2 . The measured absorbances demonstrate that at least 0.1 mL of sodium nitrite reagent is required; however, the method is not critically sensitive to the amount of added sodium nitrite over the range 0.1-0.5 mL. We chose to use 0.3 mL, to provide the same final concentration of sodium nitrite as that used in the Jendrassik-Grof method.
Rate of reaction and color stability.
We mixed 0.2 mL of a 200 g/L standard of BIL-BSA with 2 mL of SDS in a 1-cm cuvette, then added 0.6 mL of diazo reagent. The contents were mixed with a Pasteur pipette, and the change in absorbance with time was recorded at 530 nm, the wavelength of absorption maximum of azobilirubin at pH 5.6. The reaction at pH 5.6 is complete within 2 mm, and the absorbance is stable to within 0.1% for at least 1 h. The absorbance at the final pH of 1.55 is also stable to within 0.1% for at least 1 h.
Effect of protein.
From a 50-mL stock solution of bilirubin in 40 g of bovine serum albumin per liter, we transferred 6 mL into each of seven 25-mL volumetric flasks. The flasks were brought to final volume with various proportions of a 15 g/L solution of bovine serum albumin (in saline, pH 7.4) and saline to produce the desired range of protein concentrations (10-1 20 g/L). The bilirubin content of each sample was determined in duplicate, and the average absorbance for all protein concentrations was 0.829 ± 0.003 (SD), with a coefficient of variation (CV) of 0.36%. Thus for a range in serum protein concentrations of 10-120 g/L, the absorbance uncertainty was only three parts in 829, which is negligible in a routine bilirubin determination.
Linearity
Aliquots from stock solutions of approximately 250 mg of bilirubin per liter in 60 g/L solutions of bovine serum albumin or pooled human serum were pipetted into 25-caL volumetric flasks to produce final concentrations of 5, 10,50, 100, 150,200, and 250 mg/L when diluted with bovine serum albumin, pooled serum, or saline. All measurements were performed in duplicate and the results are shown in Table 3 . When saline was used as the diluent, the protein concentration ranged from 1.2 to 60 g/L and, consequently, we could assess simultaneously both the linearity of the standard curve of the method and the effect of protein concentration.
For a given protein matrix, the curve for concentration vs absorbance with the SDS method is linear from 0 to 250 mg of bilirubin per liter; this linearity is not affected by variable protein concentrations in the range of 1.2-60 g/L for bovine serum albumin or pooled serum (see above, Effect of protein). 
Molar Absorptivity
Correlation of Methods for the Analysis of Total Bilirubin
Effect of Hemoglobin
A 100 g/L stock solution of hemoglobin (Hb) was prepared from washed erythrocytes by freezing and thawing in water. Concentrations were determined by a spectrophotometric method (11). Necessary dilutions were made with de-ionized water. Standard solutions containing Hb and bilirubin in pooled serum were made in 25-mL volumetric flasks to final Hb concentrations of 1.0, 2.5, 5.0, and 10.0 g/L. We studied analytical recovery by measuring the amounts of bilirubin in samples with and without added Hb.
The results of the recovery studies for the SDS method with and without caffeine and for the Jendrassik-Grof method are shown in Table 4 . The recoveries for the SDS method with caffeine and for the Jendrassik-Grof method are comparable; however, in the absence of caffeine, the recovery for the SDS method is quite unsatisfactory at high Hb concentrations. We did not use caffeine in our initial studies on the SDS method, but when we discovered that the Hb effect was so large, we investigated the nature of the Hb interference. To determine whether the lower recoveries in the SDS method were a result of an azobilirubin-hemoglobin complex that lowered the molar absorptivity or shifted the wavelength of maximum absorbance, we added 0.1 mL of a 10 g/L solution of either bovine serum albumin or Hb to 2. (12, 13) : the formation of azobilirubin by cleavage of the central methylene bond (Figure 3 ) and the coupling of the diazonium salt with hydroxypyrromethene carbinol to form a second molecule of azobilirubin.
The similarity of the pyrrole moieties of bilirubin and of hydroxypyrromethene carbinol to the structures of compounds known to bind heme (14) is suggestive of a possible heme inhibition through the formation of a heme-bilirubin or a heme-hydroxypyrromethene carbinol complex.
An example of such a complex between the pyrrole moiety of hydroxypyrromethene carbinol and heme is depicted schematically in Figure 3 and, as shown, would inhibit formation of the second molecule of azobilirubin. We emphasize that we have no direct evidence for the existence of either complex described above; however, our experimental observation that recoveries are inversely proportional to the concentration of Hb and directly proportional to the concentration of bilirubin (Table 4) is consistent with the existence of either one or both of these complexes. we made analytical recovery studies. To 0.1 mL of de-ionized water or 0.1 mL of hemoglobin stock solution (100 g/L) we added 0.1 mL of bilirubin (100 mg/L) in bovine serum albumin. We then added 0.1 mL of the heme-binding compound, diazotized the samples as described in Materials and Methods, and determined the absorbances at 565 nm. The results, shown in Table 6 , demonstrate that, although the effect of Hb interference could not be entirely eliminated at high concentrations, recovery could be substantially increased with the addition of heme-binding compounds.
We have chosen to use caffeine in our method because it is inexpensive, readily available, safe, and easy to handle. The caffeine used as an accelerator in the Jendrassik-Grof method undoubtedly aids in reducing Hb interference.
Conjugated Bilirubin
Because primary standard bilirubin glucuronides are not available, nothing is known about the absolute accuracy of any method for measuring conjugated bilirubin. We have observed widely divergent results with different methods in current use. However, with a given method, relative estimates of conjugated bilirubin can provide clinically useful information.
We have therefore used the reagents optimized for total bilirubin analysis to develop a method for conjugated bilirubin by adjusting reagent volumes to obtain results identical to those of the Jendrassik-Grof method described in Material and Methods.
Our method for conjugated bilirubin thus compares well with a method that has experienced widespread clinical usage (5) . Beyond stating that our method for conjugated bilirubin produces clinically useful results, we make no statements about the accuracy of this or any method for conjugated bilirubin.
Action of SDS
Although we have not performed experiments to elucidate the details by which SDS promotes the release of bilirubin from serum albumin, we feel that it is instructive to point out some of the possible modes of action based upon and consistent with published observations of the interaction between SDS and serum albumin.
The interaction between detergents and proteins has been the subject of laboratory investigation for over four decades and has been extensively reviewed (15) (16) (17) (18) . SDS has been shown to bind to serum albumin through a combined ionic and hydrophobic interaction (18) (19) (20) . Charged groups of serum albumin interact with the ionic head group of SDS, and hydrophobic regions interact with the hydrocarbon tail of the detergent molecule. There are about 10-12 high-affinity binding sites for SDS in serum albumin (18, 21) and, although they are usually saturated at low detergent concentrations, this binding has a minimal effect on protein conformation. Binding to additional sites of lower affinity is thought to result from exposure of weaker binding sites in a cooperative alteration of the native structure of the protein; when more than about 20 molecules of SDS have been bound, the protein undergoes a series of denatured states. In the SDS method we describe, the concentration of SDS during the diazotization of bilirubin is 0.124 mol/L (total volume 1.4 mL) and the approximate molar ratio of SDS to protein ranges from 1000:1 (lOg/L protein) to 100:1 (120g/L protein).
At the ionic strength used in this test the critical micelle concentration3
is on the order of 1 mmol/L (19, 22, 23 (27) . These compounds have been used alone and in some combination with each other. Lolekha and Limpavithayakul (28) have shown that acetate, urea, or caffeine used alone, unless in very high concentrations, will not promote the complete release of bilirubin. However, when these reagents are combined, release is complete at much lower concentrations of each reagent, which strongly suggests that an effective accelerator must be capable of both ionic and hydrophobic interactions; SDS, by virtue of its amphiphilic nature, meets these requirements.
Once bilirubin is released from serum albumin, the bilirubin will almost certainly partition between the micelles and the solvent.4'5 SDS can release heme from hemoglobin and this free heme as well as the caffeine can partition into the micelles along with serum components such as cholesterol (29) . Porphyrins are known to partition into SDS micelles (30, 31) determined (32) . The hemin is thought to be located radially in the micelle with the carboxyl groups facing outward toward the solvent (32, 33) and with the iron also available to the aqueous environment. 4 It is possible that, in the presence of SDS at pH 5.6, any intramolecular hydrogen bonds in bilirubin (which result in a rigid, folded configuration) will be broken and the bilirubin will exist in its linear tetrapyrrole configuration (13, 34, 35) . Under these conditions, the bilirubin ought to be oriented in the micelle such that the pyrrole nitrogens face the inner hydrocarbon core and the carboxyl groups face the solvent. Because the reactive site of the bilirubin is located in a hydrophobic region, it is very unlikely that the charged diazonium salt will be able to penetrate into the inner region of the micelle to react with the bilirubin. Consequently, we believe that the diazo coupling takes place in solution and not in the micelle. Thermodynamic considerations dictate that, as bilirubin is removed from solution by diazo coupling to form azobilirubin, more bilirubin must leave the micelle for the solvent and can then react with the diazonium salt. Because only a small amount of bilirubin will be in solution at any time, a small amount of heme can cause the observed heme interference. In addition, at the pH at which the absorbance is determined (pH 1.55), the azobilirubin can also partition into the micelles.
The small amount of precipitation that occurs upon addition of SDS to the reaction mixture in our conjugated bilirubin method is not unexpected. 
Matrix Effects
The potential effect of the protein matrix on bilirubin studies cannot be disregarded.
Although bilirubin is normally optically inactive (37, 38) , circular dichroism and optical rotatory dispersion measurements reveal large Cotton effects when bilirubin is bound in the presence of molar excess of human, bovine, rabbit, goat, porcine, and chicken serum albumin (37) (38) (39) . Both the signs and magnitudes of these Cotton effects differ widely in these different matrixes, as do the magnitudes of the apparent association constants (40) . These measurements offer compelling evidence that bilirubin is bound in a coiled conformation believed to form as the molecule twists about the central methylene carbon in a relatively tight helical structure (37, 38) . Because the Cotton effects change sign at about pH 5, the helical conformation is probably modified by changes in the ionization of binding groups and by pH-dependent changes in the protein conformation. The variations among the different proteins are considered to reflect subtle differences at the respective binding sites of the albumin.
For the two most commonly used protein matrixes in bilirubin studies, human serum albumin and bovine serum albumin, the Cotton effects in the region of 300-500 nm have opposite signs; furthermore, the binding association constant for human serum albumin is approximately five-to 10-fold that for bovine serum albumin (40, 42, 43) . These conformational differences in the binding site could, together with different affinities of binding, substantially affect the ability of various accelerators to release biirubin from serum albumin.
The circular dichroism spectra also suggest that the bilirubin-binding characteristics of serum albumin are strongly dependent upon the anion concentrations (44) . Addition of anions at constant pH results in a change in the sign of the Cotton effect in the visible region, which is consistent with a change in the conformation of bound bilirubin. The anions can influence the bilirubin conformation both directly, though interaction with the charged groups that participate in the binding site, and indirectly, through interaction with distant charged groups, thereby inducing a change in the overall protein conformation.
Significant differences in the circular dichroism spectra in the visible region have been reported between charcoaltreated and untreated human serum albumin (45) . Untreated human serum albumin produced an additional small band centered at 500-510 nm. These differences were attributed to possible conformational changes in the protein matrix induced by the removal of fatty acids as well as by a possible decrease in thiol content. In contrast, the absorption spectrum of human serum albumin was unaffected by treatment with charcoal.
Moreover 
